Global and United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026

Global and United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 Other Infectious Disease POC
1.3 Market by Application
1.3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Perspective (2015-2026)
2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Growth Trends by Regions
2.2.1 Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Share by Regions (2015-2020)
2.2.3 Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Market Size
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Revenue (2015-2020)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Players (2015-2020)
3.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point-of-Care Infectious Disease Diagnostics/Testing Revenue
3.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
3.5 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Area Served
3.6 Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
3.7 Date of Enter into Point-of-Care Infectious Disease Diagnostics/Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Type (2015-2026)
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Type (2015-2020)
4.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Type (2021-2026)
5 Point-of-Care Infectious Disease Diagnostics/Testing Breakdown Data by Application (2015-2026)
5.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Historic Market Size by Application (2015-2020)
5.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
6.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
6.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
6.4 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
7.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
7.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
7.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
8.2 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
8.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
8.4 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
9.2 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
9.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size (2015-2026)
10.2 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020))
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Details
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.4.5 Siemens Healthineers Recent Development
11.5 BD & Company
11.5.1 BD & Company Company Details
11.5.2 BD & Company Business Overview
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.5.5 BD & Company Recent Development
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Details
11.6.2 Chembio Diagnostics Inc. Business Overview
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.6.5 Chembio Diagnostics Inc. Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Details
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Details
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Details
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.9.5 Quest Diagnostics Inc. Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Details
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
11.12 Sight Diagnostics Ltd.
10.12.1 Sight Diagnostics Ltd. Company Details
10.12.2 Sight Diagnostics Ltd. Business Overview
10.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.12.5 Sight Diagnostics Ltd. Recent Development
11.13 Gene POC
10.13.1 Gene POC Company Details
10.13.2 Gene POC Business Overview
10.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
10.14.1 Trivitron Healthcare Company Details
10.14.2 Trivitron Healthcare Business Overview
10.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio Ltd.
10.15.1 OJ-Bio Ltd. Company Details
10.15.2 OJ-Bio Ltd. Business Overview
10.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.15.5 OJ-Bio Ltd. Recent Development
11.16 Ortho-Clinical Diagnostics
10.16.1 Ortho-Clinical Diagnostics Company Details
10.16.2 Ortho-Clinical Diagnostics Business Overview
10.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Introduction
10.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
10.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of HIV POC
Table 4. Key Players of Clostridium difficile POC
Table 5. Key Players of HBV POC
Table 6. Key Players of Pneumonia or Streptococcus associated infections
Table 7. Key Players of Respiratory syncytial virus (RSV) POC
Table 8. Key Players of HPV POC
Table 9. Key Players of Influenza/Flu POC
Table 10. Key Players of Other Infectious Disease POC
Table 11. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2015-2020)
Table 15. Global Point-of-Care Infectious Disease Diagnostics/Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
Table 17. Point-of-Care Infectious Disease Diagnostics/Testing Market Market Trends
Table 18. Point-of-Care Infectious Disease Diagnostics/Testing Market Drivers
Table 19. Point-of-Care Infectious Disease Diagnostics/Testing Market Challenges
Table 20. Point-of-Care Infectious Disease Diagnostics/Testing Market Restraints
Table 21. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Players (2015-2020) (US$ Million)
Table 22. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players (2015-2020)
Table 23. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019)
Table 24. Global Point-of-Care Infectious Disease Diagnostics/Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Point-of-Care Infectious Disease Diagnostics/Testing Product Solution and Service
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 29. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Type (2015-2020)
Table 30. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type (2021-2026)
Table 31. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2015-2020)
Table 32. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 33. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2021-2026)
Table 34. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 35. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 36. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 37. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 38. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 39. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 40. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 41. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 42. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 43. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 44. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 45. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 46. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 47. China Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 48. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 49. China Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 50. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Region (US$ Million) (2015-2020)
Table 51. China Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Region (2015-2020)
Table 52. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 53. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 54. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 55. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 56. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 57. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 58. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020) (US$ Million)
Table 59. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020) (US$ Million)
Table 61. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application (2015-2020)
Table 62. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Country (US$ Million) (2015-2020)
Table 63. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Country (2015-2020)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Product
Table 67. Abbott Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 68. Abbott Recent Development
Table 69. Thermo Fisher Scientific Inc Company Details
Table 70. Thermo Fisher Scientific Inc Business Overview
Table 71. Thermo Fisher Scientific Inc Product
Table 72. Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 73. Thermo Fisher Scientific Inc Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Details
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. Siemens Healthineers Company Details
Table 80. Siemens Healthineers Business Overview
Table 81. Siemens Healthineers Product
Table 82. Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 83. Siemens Healthineers Recent Development
Table 84. BD & Company Company Details
Table 85. BD & Company Business Overview
Table 86. BD & Company Product
Table 87. BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 88. BD & Company Recent Development
Table 89. Chembio Diagnostics Inc. Company Details
Table 90. Chembio Diagnostics Inc. Business Overview
Table 91. Chembio Diagnostics Inc. Product
Table 92. Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 93. Chembio Diagnostics Inc. Recent Development
Table 94. Trinity Biotech Company Details
Table 95. Trinity Biotech Business Overview
Table 96. Trinity Biotech Product
Table 97. Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 98. Trinity Biotech Recent Development
Table 99. Cardinal Health Business Overview
Table 100. Cardinal Health Product
Table 101. Cardinal Health Company Details
Table 102. Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 103. Cardinal Health Recent Development
Table 104. Quest Diagnostics Inc. Company Details
Table 105. Quest Diagnostics Inc. Business Overview
Table 106. Quest Diagnostics Inc. Product
Table 107. Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 108. Quest Diagnostics Inc. Recent Development
Table 109. Bio-Rad Labs Inc. Company Details
Table 110. Bio-Rad Labs Inc. Business Overview
Table 111. Bio-Rad Labs Inc. Product
Table 112. Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 113. Bio-Rad Labs Inc. Recent Development
Table 114. bioMérieux SA Company Details
Table 115. bioMérieux SA Business Overview
Table 116. bioMérieux SA Product
Table 117. bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 118. bioMérieux SA Recent Development
Table 119. Sight Diagnostics Ltd. Company Details
Table 120. Sight Diagnostics Ltd. Business Overview
Table 121. Sight Diagnostics Ltd. Product
Table 122. Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 123. Sight Diagnostics Ltd. Recent Development
Table 124. Gene POC Company Details
Table 125. Gene POC Business Overview
Table 126. Gene POC Product
Table 127. Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 128. Gene POC Recent Development
Table 129. Trivitron Healthcare Company Details
Table 130. Trivitron Healthcare Business Overview
Table 131. Trivitron Healthcare Product
Table 132. Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 133. Trivitron Healthcare Recent Development
Table 134. OJ-Bio Ltd. Company Details
Table 135. OJ-Bio Ltd. Business Overview
Table 136. OJ-Bio Ltd. Product
Table 137. OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 138. OJ-Bio Ltd. Recent Development
Table 139. Ortho-Clinical Diagnostics Company Details
Table 140. Ortho-Clinical Diagnostics Business Overview
Table 141. Ortho-Clinical Diagnostics Product
Table 142. Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020) (US$ Million)
Table 143. Ortho-Clinical Diagnostics Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Type: 2020 VS 2026
Figure 2. HIV POC Features
Figure 3. Clostridium difficile POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus associated infections Features
Figure 6. Respiratory syncytial virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. Other Infectious Disease POC Features
Figure 10. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Home Case Studies
Figure 14. Assisted Living Healthcare Facilities Case Studies
Figure 15. Laboratories Case Studies
Figure 16. Others Case Studies
Figure 17. Point-of-Care Infectious Disease Diagnostics/Testing Report Years Considered
Figure 18. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 19. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions: 2020 VS 2026
Figure 20. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Regions (2021-2026)
Figure 21. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Players in 2019
Figure 22. Global Top Point-of-Care Infectious Disease Diagnostics/Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Infectious Disease Diagnostics/Testing as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics/Testing Revenue in 2019
Figure 24. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Canada Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Germany Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. France Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. U.K. Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Italy Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Russia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Nordic Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. China Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. South Korea Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. India Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Australia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Latin America Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Mexico Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Brazil Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Turkey Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. UAE Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 50. Rest of Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 51. Abbott Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 52. Thermo Fisher Scientific Inc Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 53. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 54. Siemens Healthineers Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 55. BD & Company Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 56. Chembio Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 57. Trinity Biotech Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 58. Cardinal Health Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 59. Quest Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 60. Bio-Rad Labs Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 61. bioMérieux SA Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 62. Sight Diagnostics Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 63. Gene POC Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 64. Trivitron Healthcare Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 65. OJ-Bio Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 66. Ortho-Clinical Diagnostics Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics/Testing Business (2015-2020)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs